Back to Journals » Drug Design, Development and Therapy » Volume 5

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer

Total article views   HTML views PDF downloads Totals
43,854 Dovepress* 21,183+ 3,688 24,871
PubMed Central* 22,671 3,799 26,470
Totals 43,854 7,487 51,341
*Since 10 March 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 1 7

View citations on PubMed Central and Google Scholar